Achilles Therapeutics Cash Flow Statement 2019-2024 | ACHL

Fifteen years of historical annual cash flow statements for Achilles Therapeutics (ACHL).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-69.67$-71.18$-61.10$-33.20$-13.99
$4.71$3.69$3.29$0.77$0.30
$6.09$13.91$6.46$4.17$0.72
$10.81$17.60$9.75$4.94$1.03
$0$0$0$0$0
$0$0$0$0$0
$0.26$1.91$-2.57$5.26$0.55
$11.28$-7.08$-10.29$-5.31$-2.60
$10.41$-5.96$-7.93$3.00$-1.18
$-48.45$-59.54$-59.28$-25.25$-14.14
$-1.10$-7.51$-7.63$-11.85$-0.94
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$-1.10$-7.51$-7.63$-11.85$-0.94
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0.01$0.00$161$0$0
$0.01$0.00$161$114$93.62
$0$0$0$0$0
$0$0$0$-0.12$0
$0.01$0.00$161$114$93.62
$-41.80$-92.98$88.50$80.26$86.91
$6.36$7.02$6.32$2.99$0.72
$0$0$0$0$0